NBTK.DE vs. BBH
Compare and contrast key facts about Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and VanEck Vectors Biotech ETF (BBH).
NBTK.DE and BBH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. NBTK.DE is a passively managed fund by Invesco that tracks the performance of the Nasdaq Biotechnology. It was launched on Nov 6, 2014. BBH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Biotech 25 Index. It was launched on Dec 20, 2011. Both NBTK.DE and BBH are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NBTK.DE or BBH.
Correlation
The correlation between NBTK.DE and BBH is 0.62, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
NBTK.DE vs. BBH - Performance Comparison
Key characteristics
NBTK.DE:
0.32
BBH:
-0.01
NBTK.DE:
0.55
BBH:
0.10
NBTK.DE:
1.07
BBH:
1.01
NBTK.DE:
0.32
BBH:
-0.01
NBTK.DE:
1.10
BBH:
-0.03
NBTK.DE:
5.11%
BBH:
6.08%
NBTK.DE:
17.67%
BBH:
16.80%
NBTK.DE:
-30.99%
BBH:
-72.69%
NBTK.DE:
-7.93%
BBH:
-25.88%
Returns By Period
In the year-to-date period, NBTK.DE achieves a 2.58% return, which is significantly higher than BBH's 2.27% return.
NBTK.DE
2.58%
1.70%
0.36%
5.62%
4.03%
N/A
BBH
2.27%
-0.10%
-8.57%
1.58%
2.78%
3.18%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
NBTK.DE vs. BBH - Expense Ratio Comparison
NBTK.DE has a 0.40% expense ratio, which is higher than BBH's 0.35% expense ratio.
Risk-Adjusted Performance
NBTK.DE vs. BBH — Risk-Adjusted Performance Rank
NBTK.DE
BBH
NBTK.DE vs. BBH - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NBTK.DE vs. BBH - Dividend Comparison
NBTK.DE has not paid dividends to shareholders, while BBH's dividend yield for the trailing twelve months is around 0.78%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
NBTK.DE Invesco Nasdaq Biotech UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BBH VanEck Vectors Biotech ETF | 0.78% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
Drawdowns
NBTK.DE vs. BBH - Drawdown Comparison
The maximum NBTK.DE drawdown since its inception was -30.99%, smaller than the maximum BBH drawdown of -72.69%. Use the drawdown chart below to compare losses from any high point for NBTK.DE and BBH. For additional features, visit the drawdowns tool.
Volatility
NBTK.DE vs. BBH - Volatility Comparison
Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) and VanEck Vectors Biotech ETF (BBH) have volatilities of 5.66% and 5.65%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.